For instance, researchhas shown that proliferation of MG can be stopped via molecular pathwayinhibition of the ERK1/2 and PI3K/AKT pathways, which results in a moderateproliferation of MG that is beneficial to upregulate the production ofneurotrophic factors, [193]. The gene discussed is AKT1; the disease is myasthenia gravis.